“A Randomized, Double-Blind, Placebo-Controlled, Phase 1 2a Trial Protocol to Assess the Safety and Efficacy of TAK-101 Administered by Microneedles in Patients With Celiac Disease”. Principles and Practice of Clinical Research, vol. 8, no. 3, Dec. 2022, pp. 37-48, https://doi.org/10.21801/ppcrj.2022.83.5.